Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134048) titled 'The Safety of Simplified Tranexamic Acid Regimen:A Pilot study' on Oct. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The second affiliated hospital of Zhejiang University school of medicine
Condition:
Traumatic Hemorrhage
Intervention:
Simplified Regimen:TXA is administered intravenously within 3 hours of injury at a loading dose of 2 g, with the infusion completed over at least 20 minutes
no second dose is given.
Divided-Dose Regimen:TXA is administered intravenously within 3 hours of injury
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-...